Overview

The Use of Anti-oxidants to Reduce Sequela of Mild Traumatic Brain Injury (mTBI) After Blast Exposure

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The administration of N-acetyl-cysteine (an anti-oxidant) for seven days along with observation will result in improved hearing and balance function in individuals who demonstrate these disorders after blast exposure when compared to a placebo medicine and observation at the seven day time point.
Phase:
N/A
Details
Lead Sponsor:
Brooke Army Medical Center
Treatments:
Acetylcysteine
Antioxidants
N-monoacetylcystine